Mark Jarvis | Director
The Newcastle upon Tyne Hospitals NHS Foundation Trust

I have overall responsibility for Newcastle Advanced Therapies and the development of advanced therapies within Newcastle Hospitals and Newcastle University. We are recognised nationally and internationally for the implementation and delivery of advanced therapies. We improve access to innovative treatments, through expert services in processing, storing and manufacturing cell, gene, and tissue products. We do this on behalf of the NHS, research institutions and industry. We operate a fully accredited (JACIE and QAAPs) and licensed (MHRA and HTA) GMP cleanroom facility across two sites at the Royal Victoria Infirmary (cell, gene and tissue laboratory) and the International Centre for Life (GMP manufacturing facility). Our well-established haematology transplant service works in close collaboration with clinical teams and expertise to deliver clinical trials for advance therapy medicinal products (ATMP) in partnership with Newcastle University.